CD200 is up-regulated in R6/1 transgenic mouse model of Huntington's disease

Andrea Comella Bolla; Tony Valente; Andres Miguez; Veronica Brito; Silvia Gines; Carme Solà; Marco Straccia; Josep M. Canals

doi:10.1371/journal.pone.0224901

Loading metrics

Open Access

Peer-reviewed

Research Article

CD200 is up-regulated in R6/1 transgenic mouse model of Huntington's disease

Andrea Comella Bolla ,

Contributed equally to this work with: Andrea Comella Bolla, Marco Straccia

Roles Formal analysis, Investigation

Affiliations Stem Cells and Regenerative Medicine Laboratory, Production and Validation Center of Advanced Therapies (Creatio), Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain, Neuroscience Institute, University of Barcelona, Barcelona, Spain, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain, Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain
⨯
Tony Valente,

Roles Formal analysis, Investigation

Affiliations August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain, Department of Cerebral Ischemia and Neurodegeneration, Institut d’Investigacions Biomèdiques de Barcelona–Consejo Superior de Investigaciones Científicas (IIBB–CSIC), Barcelona, Spain
⨯
Andres Miguez,

Roles Formal analysis, Investigation

Affiliations Stem Cells and Regenerative Medicine Laboratory, Production and Validation Center of Advanced Therapies (Creatio), Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain, Neuroscience Institute, University of Barcelona, Barcelona, Spain, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain, Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain

http://orcid.org/0000-0001-6014-3685

⨯
Veronica Brito,

Roles Formal analysis, Investigation

Affiliations Neuroscience Institute, University of Barcelona, Barcelona, Spain, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain, Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain
⨯
Silvia Gines,

Roles Formal analysis, Investigation

Affiliations Neuroscience Institute, University of Barcelona, Barcelona, Spain, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain, Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain
⨯
Carme Solà,

Roles Conceptualization, Formal analysis, Investigation

Affiliations August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain, Department of Cerebral Ischemia and Neurodegeneration, Institut d’Investigacions Biomèdiques de Barcelona–Consejo Superior de Investigaciones Científicas (IIBB–CSIC), Barcelona, Spain
⨯
Marco Straccia ,

Contributed equally to this work with: Andrea Comella Bolla, Marco Straccia

Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Supervision, Writing – original draft

* E-mail: marco.straccia@fre-sci.info (MS); jmcanals@ub.edu (JMC)

Current address: FRESCI, Freelance Scientists, Human Technology Consultants– www.fre-sci.com

Affiliations Stem Cells and Regenerative Medicine Laboratory, Production and Validation Center of Advanced Therapies (Creatio), Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain, Neuroscience Institute, University of Barcelona, Barcelona, Spain, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain, Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain

http://orcid.org/0000-0003-3903-4163

⨯
Josep M. Canals

Roles Conceptualization, Data curation, Funding acquisition, Investigation, Project administration, Resources, Supervision, Writing – review & editing

* E-mail: marco.straccia@fre-sci.info (MS); jmcanals@ub.edu (JMC)

Affiliations Stem Cells and Regenerative Medicine Laboratory, Production and Validation Center of Advanced Therapies (Creatio), Department of Biomedicine, Faculty of Medicine and Health Science, University of Barcelona, Barcelona, Spain, Neuroscience Institute, University of Barcelona, Barcelona, Spain, August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain, Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain

http://orcid.org/0000-0001-6829-7670

⨯

CD200 is up-regulated in R6/1 transgenic mouse model of Huntington's disease

Andrea Comella Bolla,
Tony Valente,
Andres Miguez,
Veronica Brito,
Silvia Gines,
Carme Solà,
Marco Straccia,
Josep M. Canals

Published: December 2, 2019
https://doi.org/10.1371/journal.pone.0224901

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Mouse models
Is the Subject Area "Mouse models" applicable to this article?

Thanks for your feedback.
Hippocampus
Is the Subject Area "Hippocampus" applicable to this article?

Thanks for your feedback.
Neostriatum
Is the Subject Area "Neostriatum" applicable to this article?

Thanks for your feedback.
Neocortex
Is the Subject Area "Neocortex" applicable to this article?

Thanks for your feedback.
Blood
Is the Subject Area "Blood" applicable to this article?

Thanks for your feedback.
Gene expression
Is the Subject Area "Gene expression" applicable to this article?

Thanks for your feedback.
Central nervous system
Is the Subject Area "Central nervous system" applicable to this article?

Thanks for your feedback.
Microglial cells
Is the Subject Area "Microglial cells" applicable to this article?

Thanks for your feedback.